A comparator drug is included in clinical trials:
o if the new compound is anticipated to be less expensive than existing therapy.
o if an approved drug is available with a similar chemical structure.
o when the sponsor hopes to make a claim of increased efficacy.
o when another drug is in clinical trials for the same indication.